TY  - JOUR
AU  - Tramsen, Lars
AU  - Bochennek, Konrad
AU  - Sparber-Sauer, Monika
AU  - Salzmann-Manrique, Emilia
AU  - Scheer, Monika
AU  - Dantonello, Tobias
AU  - Borkhardt, Arndt
AU  - Dirksen, Uta
AU  - Thorwarth, Anne
AU  - Greiner, Jeanette
AU  - Ebinger, Martin
AU  - Weclawek-Tompol, Jadwiga
AU  - Ladenstein, Ruth
AU  - Ljungman, Gustaf
AU  - Hallmen, Erika
AU  - Lehrnbecher, Thomas
AU  - Koscielniak, Ewa
AU  - Klingebiel, Thomas
TI  - Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.
JO  - Cancers
VL  - 15
IS  - 7
SN  - 2072-6694
CY  - Basel
PB  - MDPI
M1  - DKFZ-2023-00769
SP  - 2050
PY  - 2023
AB  - Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma (STS) in childhood. Whereas more than 90
KW  - children (Other)
KW  - long-term maintenance therapy (Other)
KW  - metastatic (Other)
KW  - outcome (Other)
KW  - rhabdomyosarcoma (Other)
KW  - soft tissue sarcoma (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37046711
C2  - pmc:PMC10093505
DO  - DOI:10.3390/cancers15072050
UR  - https://inrepo02.dkfz.de/record/275449
ER  -